SmartTRAK highlights four wound companies to watch in 2026 with new-generation antimicrobial alternatives
- Bacteria are becoming resistant to silver, making it less effective.
- Several existing antimicrobial technologies may induce cytotoxic effects.
- Silver dressings are commoditized, and the market is hungry for novel and innovative alternatives.
- Stricter medical rules (antimicrobial stewardship) now require clinicians to be more careful about how they use germ-killing treatments, as there has been a widespread habit of using these dressings on wounds that do not actually need them.
In the complete downloadable article, SmartTRAK highlights in detail four companies to watch in 2026 with advanced dressings that offer new approaches to attacking bioburden and infection while limiting antimicrobial resistance. They are:
-
Convatec: Seeing Great Potential with ConvaNiox
Convatec is the global leader in the antimicrobial dressings market with its Aquacel Ag range. It is evident that they are convinced that ConvaNiox will be their next big brand in wound care ... (read more) -
Polaroid Therapeutics
Polaroid Therapeutics (PTx) is a Swiss-based biotech start-up developing innovative products and solutions using its proprietary novel antimicrobial technology ... (read more) -
Amferia: Replacing Chemical Leaching with Targeted Peptide Innovation
Amferia’s competitive advantage lies in its proprietary antimicrobial peptide (AMP) hydrogel platform ... (read more) -
Nanordica Medical: Addressing the Silver Paradox
Nanordica Medical stands out in the antimicrobial landscape by addressing the critical trade-off between efficacy and cytotoxicity. Nanordica has pioneered a synergistic copper-silver nanotechnology ...(read more)
Want to learn more about these companies and their next-generation antimicrobial solutions? Click the button below to read the full "Attacking Bioburden and Infection: Four Advanced Dressing Companies to Watch in 2026" article written by Lennart Stadler, SmartTRAK's GM Consulting & Sr Analyst Wound and Anikó Szekér, Sr Analyst, Wound.
SmartTRAK is the Medtech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. SmartTRAK’s proprietary methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK enterprise platform includes rich daily updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product and financial analysis. Customers leveraging the SmartTRAK platform also have direct access to market experts for inquiries and advisory services. If you would like a demo of what SmartTRAK has to offer and see how we can help increase proficiency, improve productivity and reduce costs for your company, just click here.
